World of DTC Marketing
JUNE 21, 2025
It’s a basic principle: the healthcare system exists to serve patients. Yet, astonishingly, the very institutions tasked with protecting and managing our healthcare can sometimes become a threat to patient safety. When incompetence infiltrates government agencies overseeing healthcare—through bureaucratic inertia, outdated policies, or poorly informed decisions—it’s patients who ultimately pay the price.
Bio Pharma Dive
JUNE 23, 2025
While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s version of psilocybin could be as a depression treatment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 23, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
Rethinking Clinical Trials
JUNE 23, 2025
A new section of the Living Textbook of Pragmatic Clinical Trials describes considerations for choosing patient-reported outcome measures in pragmatic clinical trials. “Where possible, investigators are encouraged to use measures with adequate support for validity that are in the public domain,” the authors wrote. The authors provide a set of questions to guide investigators in choosing approrpriate measures.
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.
World of DTC Marketing
JUNE 23, 2025
It’s a common misconception in pharma marketing that the goal is to “sell” a medication like you’d sell a soda or smartphone. But prescription drugs aren’t consumer goods—they are interventions in people’s health, often at critical moments in their lives. Patients aren’t looking for a sales pitch. They’re looking for trust, clarity, and reassurance that the treatment being suggested is truly proper for them.
Bio Pharma Dive
JUNE 23, 2025
Can rethinking risk in R&D unlock breakthroughs for rare and hard-to-treat diseases?
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
STAT News
JUNE 22, 2025
CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on safety and efficacy, further data indicating that CagriSema may not be the standout treatment that investors had hoped for. Novo previously reported that patients on CagriSema lost 20% of their weight in a 68-week Phase 3 trial when looking at all participants, a similar level of weight loss seen in Zepbound studies.
World of DTC Marketing
JUNE 22, 2025
The American healthcare system stands at a pivotal intersection. On one path lies a vision of accessible, affordable care that prioritizes patients over profits. On the other hand, we persist in a status quo marked by soaring medical costs, heartbreaking choices between medication and necessities, and millions of people suffering because healthcare remains unaffordable.
Bio Pharma Dive
JUNE 23, 2025
Skip to main content Dont miss tomorrows biopharma industry news Let BioPharma Dives free newsletter keep you informed, straight from your inbox. Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy.
Pharmaceutical Technology
JUNE 22, 2025
David W Miller, CEO of Genesis Research Group, discusses how pharma's decade-long development approach is no longer fit for purpose.
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
Scienmag
JUNE 21, 2025
In recent years, neuroscience has increasingly uncovered the subtle ways our brain’s ongoing activity shapes how we perceive the world around us. One of the newest frontiers in this area of research focuses on the role of neural oscillations—rhythmic patterns of electrical activity—in biasing perception even before a stimulus is presented. A groundbreaking study by Forster, Stephani, Grund, and colleagues published in Communications Psychology in 2025 reveals how pre-stimulus beta power—a specif
STAT News
JUNE 23, 2025
WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. to be delayed, citing their lack of experience and potential bias against some vaccines. “Although the appointees to [the Advisory Committee on Immunization Practices] have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology.
Bio Pharma Dive
JUNE 23, 2025
The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo resolved its shortage.
Pharmaceutical Technology
JUNE 23, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Scienmag
JUNE 21, 2025
In a groundbreaking new study published in the journal Schizophrenia (2025), researchers have unveiled compelling evidence of cell-type specific gene expression reductions in the interneurons of the cingulate gyrus in individuals diagnosed with schizophrenia and bipolar disorder. This discovery not only advances our understanding of the intricate cellular and molecular alterations underlying these complex psychiatric illnesses but also opens new avenues for targeted therapeutic intervention.
STAT News
JUNE 23, 2025
CHICAGO — An investigational therapy from Eli Lilly helped preserve lean mass and drive greater loss of fat in patients taking the popular obesity treatment Wegovy. In a Phase 2 trial, patients taking the highest-dose combination of Wegovy and the drug, called bimagrumab, lost 22% of their weight at 72 weeks. Ninety-three percent of that was fat mass, and the rest was lean mass.
Bio Pharma Dive
JUNE 23, 2025
Illumina expects that adding SomaLogic will aid its “multiomics” business strategy and strengthen the value of its gene sequencing products.
Pharmaceutical Technology
JUNE 23, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Scienmag
JUNE 22, 2025
In a groundbreaking new study published in the International Journal for Equity in Health , researchers have shed light on a critical and complex public health issue affecting Latin America and the Caribbean: the underperformance of basic child vaccination programs. Drawing from an extensive cross-sectional analysis encompassing 18,136 children across 211 distinct regions in 15 countries, this study unpacks how a constellation of overlapping social, economic, and infrastructural deprivations act
STAT News
JUNE 23, 2025
WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the agency in July. Corrigan-Curay, who took over as acting director of the Center for Drug Evaluation and Research in January, broke the news to staff in an email shared with STAT. She said she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering support, especially during recent challenging times.
Medical Xpress
JUNE 23, 2025
Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful dermatologic disease, a Stanford Medicine-led clinical trial has shown. The grafts treat severe dystrophic epidermolysis bullosa, or EB, a genetic condition in which the skin is so fragile the slightest touch can cause blistering and wounds, eventually leading to large, open lesions that never heal and are immensely painful.
NPR Health - Shots
JUNE 22, 2025
Cuts to Medicaid moving through Congress would shake up health care in the scenic San Luis Valley — with negative downstream effects on local jobs, businesses and education.
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?
Scienmag
JUNE 22, 2025
In a groundbreaking study set to redefine neonatal nutritional strategies, researchers have shed new light on the crucial role of early parenteral lipid administration in supporting cerebellar neurometabolism among preterm infants at term-equivalent age. Published in the Journal of Perinatology in 2025, this pivotal research meticulously explores how tailored lipid intake can significantly influence the delicate neurodevelopmental processes during a critical window of brain growth.
STAT News
JUNE 23, 2025
CHICAGO — Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a mid-stage trial, results that support the company’s decision to use a slower dosing schedule to make the drug more tolerable in further testing. In the Phase 2 study, patients with obesity taking the injectable drug, called MariTide, lost up to 16.2% of their weight in one year when taking into account all participants regardless of disco
Medical Xpress
JUNE 23, 2025
Endoscopies could be replaced by far less invasive capsule sponge tests for half of all patients with Barrett's esophagus, a known precursor to esophageal cancer, according to a new study by researchers at the University of Cambridge, Addenbrooke's Hospital and Queen Mary University of London. The research was published in The Lancet.
NPR Health - Shots
JUNE 23, 2025
more than a dozen different disease-causing agents, including toxins, allergens, bacteria, parasites and viruses.'/> Tick bites are are on the rise this and they can carry some nasty illnesses. Which are most common depends where you live. Here's what to know to protect yourself.
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
Scienmag
JUNE 23, 2025
A groundbreaking development in the early detection of hepatocellular carcinoma (HCC) has emerged from the halls of Wuhan Union Hospital at Huazhong University of Science and Technology. Researchers have unveiled a novel molecular imaging agent, designated 68 Ga-aGPC3-scFv or XH06, capable of precisely targeting glypican-3 (GPC3), a cell surface receptor that is prevalently overexpressed in HCC tumors.
STAT News
JUNE 23, 2025
Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass compounding” of GLP-1 obesity treatments and “deceptive marketing.” Earlier this year, Novo launched a direct-to-consumer website that sells its obesity drug Wegovy at a lower price to patients who are paying on their own without insurance.
Medical Xpress
JUNE 23, 2025
Published in The Journal of Infectious Diseases, a University of Minnesota research team has demonstrated that measuring SARS-CoV-2 in wastewater continues to accurately predict COVID-19 infections in a community.
NY Times
JUNE 21, 2025
Aid cuts have reached a level where they undermine our national interest as well as corrode our souls.
Expert insights. Personalized for you.
165 
Let's personalize your content